Hybio Pharmaceutical Co.. Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 5.61% vs 111.82% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 456.86% vs 52.27% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "299.10",
          "val2": "283.20",
          "chgp": "5.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "111.20",
          "val2": "39.60",
          "chgp": "180.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "23.30",
          "val2": "25.00",
          "chgp": "-6.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "127.40",
          "val2": "-35.70",
          "chgp": "456.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "371.80%",
          "val2": "11.40%",
          "chgp": "36.04%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 63.36% vs 40.82% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 118.88% vs 65.06% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "963.20",
          "val2": "589.60",
          "chgp": "63.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "305.20",
          "val2": "109.70",
          "chgp": "178.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "114.10",
          "val2": "117.90",
          "chgp": "-3.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-12.30",
          "val2": "-82.40",
          "chgp": "85.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "34.00",
          "val2": "-180.10",
          "chgp": "118.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "172.50%",
          "val2": "-58.00%",
          "chgp": "23.05%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

299.10

283.20

5.61%

Operating Profit (PBDIT) excl Other Income

111.20

39.60

180.81%

Interest

23.30

25.00

-6.80%

Exceptional Items

-0.10

-0.00

Consolidate Net Profit

127.40

-35.70

456.86%

Operating Profit Margin (Excl OI)

371.80%

11.40%

36.04%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 5.61% vs 111.82% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 456.86% vs 52.27% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

963.20

589.60

63.36%

Operating Profit (PBDIT) excl Other Income

305.20

109.70

178.21%

Interest

114.10

117.90

-3.22%

Exceptional Items

-12.30

-82.40

85.07%

Consolidate Net Profit

34.00

-180.10

118.88%

Operating Profit Margin (Excl OI)

172.50%

-58.00%

23.05%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 63.36% vs 40.82% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 118.88% vs 65.06% in Dec 2024

All Annual Results